- Home
- CRIS vs SCNI Comparison
CRIS vs SCNI Comparison
Compare CRIS & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRIS | SCNI |
|---|---|---|
| Founded | 2000 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 1.7M |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CRIS | SCNI |
|---|---|---|
| Price | $0.64 | $1.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $42.67 | N/A |
| AVG Volume (30 Days) | 160.7K | ★ 1.3M |
| Earning Date | 11-05-2026 | 08-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | 50.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,898,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.34 | $0.21 |
| 52 Week High | $3,360.00 | $3.58 |
Technical Indicators
Market Signals| Indicator | CRIS | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 19.38 | 41.62 |
| Support Level | $0.34 | $0.47 |
| Resistance Level | $5.50 | $2.08 |
| Average True Range (ATR) | 0.08 | 0.14 |
| MACD | 1.34 | -0.06 |
| Stochastic Oscillator | 6.85 | 11.76 |
Price Performance
Historical ComparisonAbout CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.